ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Royal College of Surgeons, Ireland
- Principal Investigator
- Paul McNallyRCSI
- Intervention
- Quality of Life(other)
- Enrollment
- 550 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2023 – 2028
Collaborators
University Hospital of Limerick · Cork University Hospital · University College Hospital Galway · Belfast Health and Social Care Trust · NHS Lothian · Alder Hey Children's NHS Foundation Trust · Manchester University NHS Foundation Trust · Newcastle-upon-Tyne Hospitals NHS Trust · Cardiff and Vale University Health Board · Royal Brompton & Harefield NHS Foundation Trust · Erasmus University Rotterdam · Medizinische Hochschule Brandenburg Theodor Fontane · Massachusetts General Hospital · The Hospital for Sick Children · Teagasc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05986045 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.